80 related articles for article (PubMed ID: 26025408)
1. MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R.
Wen XP; Ma HL; Zhao LY; Zhang W; Dang CX
Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):78-85. PubMed ID: 26025408
[TBL] [Abstract][Full Text] [Related]
2. circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC).
Tang YF; Liu ZH; Zhang LY; Shi SH; Xu S; Ma JA; Hu CH; Zou FW
Mol Cancer; 2024 May; 23(1):91. PubMed ID: 38715012
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer.
Ling C; Wang X; Zhu J; Tang H; Du W; Zeng Y; Sun L; Huang JA; Liu Z
Cancer Med; 2019 Jul; 8(7):3520-3531. PubMed ID: 31074594
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicle-encapsulated microRNA-425-derived from drug-resistant cells promotes non-small-cell lung cancer progression through DAPK1-medicated PI3K/AKT pathway.
Guo Z; Ye H; Zheng X; Yin W; He J
J Cell Physiol; 2021 May; 236(5):3808-3820. PubMed ID: 33258116
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of circRNA_100876 Inhibited Progression of NSCLC In Vitro via Targeting miR-636.
Song J; Shi W; Gao Z; Liu X; Wang W
Technol Cancer Res Treat; 2020; 19():1533033820951817. PubMed ID: 33030101
[TBL] [Abstract][Full Text] [Related]
6. ZNF674-AS1 antagonizes miR-423-3p to induce G0/G1 cell cycle arrest in non-small cell lung cancer cells.
Liu Y; Huang R; Xie D; Lin X; Zheng L
Cell Mol Biol Lett; 2021 Feb; 26(1):6. PubMed ID: 33618674
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑539 inhibits the proliferation and invasion of bladder cancer cells by regulating IGF‑1R.
Liao G; Chen F; Zhong J; Jiang X
Mol Med Rep; 2018 Apr; 17(4):4917-4924. PubMed ID: 29393438
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the Role of miR-30a-5p and DLGAP1 Gene in Non-small Cell Lung Cancer.
Świtlik W; Wyżewski Z; Gregorczyk-Zboroch K; Gietler M; Pudlarz A; Szewińska J; Orzechowski S; Jakieła S; Szemraj J
Anticancer Res; 2024 Jun; 44(6):2445-2451. PubMed ID: 38821626
[TBL] [Abstract][Full Text] [Related]
9. Tumor-suppressive action of miR-30a-5p in lung adenocarcinoma correlates with ABL2 inhibition and PI3K/AKT pathway inactivation.
Miao Y; Liu J
Clin Transl Oncol; 2024 Feb; 26(2):398-413. PubMed ID: 37479901
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑21 increases cell viability and suppresses cellular apoptosis in non‑small cell lung cancer by regulating the PI3K/Akt signaling pathway.
Wang T; Cai Z; Hong G; Zheng G; Huang Y; Zhang S; Dai J
Mol Med Rep; 2017 Nov; 16(5):6506-6511. PubMed ID: 28901419
[TBL] [Abstract][Full Text] [Related]
11. A genetic variant in gene NDUFAF4 confers the risk of non-small cell lung cancer by perturbing hsa-miR-215 binding.
Long T; Li J; Yin T; Liu K; Wang Y; Long J; Wang J; Cheng L
Mol Carcinog; 2024 Jan; 63(1):145-159. PubMed ID: 37787384
[TBL] [Abstract][Full Text] [Related]
12. miR-29b Regulates Lung Cancer Progression by Downregulating FEM1B and Inhibiting the FOX01/AKT Pathway.
Zhang H; Wang R; Deng Q
Comput Math Methods Med; 2022; 2022():3110330. PubMed ID: 36003920
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/Akt pathway.
Yang F; Zheng Y; Luo Q; Zhang S; Yang S; Chen X
BMC Cancer; 2024 Apr; 24(1):408. PubMed ID: 38566039
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells.
Du B; Wang Z; Zhang X; Feng S; Wang G; He J; Zhang B
PLoS One; 2014; 9(2):e88022. PubMed ID: 24505359
[TBL] [Abstract][Full Text] [Related]
15. MiR-30a-5p inhibits proliferation and metastasis of hydatidiform mole by regulating B3GNT5 through ERK/AKT pathways.
Guo Z; Sun Q; Liao Y; Liu C; Zhao W; Li X; Liu H; Dong M; Shang Y; Sui L; Kong Y
J Cell Mol Med; 2020 Aug; 24(15):8350-8362. PubMed ID: 32575164
[TBL] [Abstract][Full Text] [Related]
16. Post-transcriptional regulation of IGF1R by key microRNAs in long-lived mutant mice.
Liang R; Khanna A; Muthusamy S; Li N; Sarojini H; Kopchick JJ; Masternak MM; Bartke A; Wang E
Aging Cell; 2011 Dec; 10(6):1080-8. PubMed ID: 21967153
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Inhibitory Effect of Berberine and Low-Temperature Plasma on Non-Small-Cell Lung Cancer Cells via PI3K-AKT-Driven Signaling Axis.
Lu T; Wang Y; Liu F; Zhang L; Huang S; Zhou Y; Wu H; Mao Y; Jin C; Song W
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067530
[TBL] [Abstract][Full Text] [Related]
18. Expression of HYOU1 via Reciprocal Crosstalk between NSCLC Cells and HUVECs Control Cancer Progression and Chemoresistance in Tumor Spheroids.
Lee M; Song Y; Choi I; Lee SY; Kim S; Kim SH; Kim J; Seo HR
Mol Cells; 2021 Jan; 44(1):50-62. PubMed ID: 33455947
[TBL] [Abstract][Full Text] [Related]
19. Pathways regulating the expression of the immunomodulatory protein glycodelin in non‑small cell lung cancer.
Weber R; Meister M; Muley T; Thomas M; Sültmann H; Warth A; Winter H; Herth FJF; Schneider MA
Int J Oncol; 2019 Feb; 54(2):515-526. PubMed ID: 30535430
[TBL] [Abstract][Full Text] [Related]
20. Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptor.
Vincent EE; Elder DJ; Curwen J; Kilgour E; Hers I; Tavaré JM
PLoS One; 2013; 8(6):e66963. PubMed ID: 23826179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
